News
Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...
Laura Davisson is an obesity medicine doctor and professor at West Virginia University, but a growing part of her job is not ...
With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.
Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It ...
Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.
A GP has called for tighter checks to prevent so-called "skinny jabs" being sold online to people who do not meet the ...
Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.
Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new data from a late-stage study of the GLP-1 receptor agonist.
A MUM has revealed she has no regrets about spending £1,200 on confidence-boosting Mounjaro – despite being in £21,000 of ...
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter</p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results